2022
Cardiac magnetic resonance for prophylactic implantable-cardioverter defibrillator therapy international study: prognostic value of cardiac magnetic resonance-derived right ventricular parameters substudy
Al’Aref S, Altibi A, Malkawi A, Mansour M, Baskaran L, Masri A, Rahmouni H, Abete R, Andreini D, Aquaro G, Barison A, Bogaert J, Camastra G, Carigi S, Carrabba N, Casavecchia G, Censi S, Cicala G, Conte E, De Cecco C, De Lazzari M, Di Giovine G, Di Roma M, Dobrovie M, Focardi M, Gaibazzi N, Gismondi A, Gravina M, Guglielmo M, Lanzillo C, Lombardi M, Lorenzoni V, Lozano-Torres J, Margonato D, Martini C, Marzo F, Masci P, Masi A, Memeo R, Moro C, Mushtaq S, Nese A, Palumbo A, Pavon A, Pedrotti P, Pepi M, Marra M, Pica S, Pradella S, Presicci C, Rabbat M, Raineri C, Rodriguez-Palomares J, Sbarbati S, Schoepf U, Squeri A, Sverzellati N, Symons R, Tat E, Timpani M, Todiere G, Valentini A, Varga-Szemes A, Volpe A, Fusini L, Guaricci A, Schwitter J, Pontone G. Cardiac magnetic resonance for prophylactic implantable-cardioverter defibrillator therapy international study: prognostic value of cardiac magnetic resonance-derived right ventricular parameters substudy. European Heart Journal - Cardiovascular Imaging 2022, 24: 472-482. PMID: 35792682, PMCID: PMC10029842, DOI: 10.1093/ehjci/jeac124.Peer-Reviewed Original ResearchConceptsRight ventricular systolic dysfunctionCardiac magnetic resonanceAll-cause mortalityPredictor of all-cause mortalityRV ejection fractionPrognostic valueEjection fractionSystolic dysfunctionHeart failureQuantitative assessment of RV functionMean left ventricular ejection fractionAssessment of RV functionBaseline cardiac magnetic resonanceRV systolic dysfunctionRV systolic functionMedian follow-upNormal renal functionVentricular systolic dysfunctionVentricular ejection fractionReduced ejection fractionKaplan-Meier curvesRV functionNYHA III/IVSystolic functionRenal dysfunction
2021
Transfemoral versus transapical approach for transcatheter aortic valve implantation: a systematic review and meta-analysis of adjusted studies
Hage F, Harris A, Clerc O, Altibi A, Hage A, Hamaya R, Papatheodorou S. Transfemoral versus transapical approach for transcatheter aortic valve implantation: a systematic review and meta-analysis of adjusted studies. European Heart Journal 2021, 42: ehab724.1624. DOI: 10.1093/eurheartj/ehab724.1624.Peer-Reviewed Original ResearchTranscatheter aortic valve implantationMid-term mortalityAcute kidney injuryAortic valve implantationTA-TAVIMeta-analysisKidney injuryVascular complicationsValve implantationPacemaker requirementHazard ratioOdds ratioMyocardial infarctionStandard surgical replacementHigher postoperative mortalityPostoperative aortic regurgitationAssociated with reduced vascular complicationsPerioperative surgical complicationsFollow-up durationSevere aortic stenosisKaplan-Meier curvesLong follow-upLong-term outcomesComorbidities of patientsMeta-analysis of studies
2017
A meta-analysis of prognostic roles of molecular markers in papillary thyroid carcinoma
Vuong H, Duong U, Altibi A, Ngo H, Pham T, Tran H, Gandolfi G, Hassell L. A meta-analysis of prognostic roles of molecular markers in papillary thyroid carcinoma. Endocrine Connections 2017, 6: r8-r17. PMID: 28219937, PMCID: PMC5424840, DOI: 10.1530/ec-17-0010.Peer-Reviewed Original ResearchDisease-specific survivalDisease-free survivalPapillary thyroid carcinomaKaplan-Meier curvesPromoter mutationsHazard ratioPrognostic roleThyroid carcinomaData of hazard ratioVirtual Health LibraryAssess patient prognosisPooled hazard ratioInverse variance methodConfidence intervalsPrognosis of PTC patientsPredicting patient outcomesVisual inspection of funnel plotsMeta-analysesInspection of funnel plotsRandom-effects modelPrognostic valuePTC patientsEgger's regression testRisk stratificationPatient prognosis